As a global leader in cancer research and care, Sarah Cannon focuses on providing greater access to innovative therapies to patients close to home. The new 12,000-square-foot Sarah Cannon Research Institute at Tennessee Oncology Franklin Drug Development Unit (DDU) and Sarah Cannon Research Institute at Florida Cancer Specialists Lake Nona DDU bring together cutting-edge cancer treatments, advanced diagnostics and research in one location, providing convenient access for patients and their support systems in their own communities.
The Drug Development Units elevate the patient experience with comfortable, amenity-filled private, semi-private and open treatment spaces and large expanses of windows that flood the space with natural light. the DDUs eliminate bottlenecks by separating patient intake functions from patient treatment areas and increase efficiency with centrally-located supply and drug storage rooms. The layout also creates synergies for care team members as they move between “on stage” areas, which support patient interaction and observation, and “off stage” work areas, which support charting, collaboration and consultation amongst the care team. Work stations are strategically positioned for proximity, safety and visibility, while adjacent focus rooms and research workrooms serve as a physical and metaphorical hinge point between treatment and research.